|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.8 NOK | +2.51% |
|
+8.51% | -1.69% |
| Apr. 29 | Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors | CI |
| Apr. 29 | Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO | CI |
Gentian Diagnostics ASA reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was NOK 27.91 million compared to NOK 21.73 million a year ago. Revenue was NOK 30.87 million compared to NOK 24.94 million a year ago.
Net loss was NOK 4.63 million compared to NOK 9.58 million a year ago. Basic loss per share from continuing operations was NOK 0.3 compared to NOK 0.621 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.69% | 55.83M | |
| -0.60% | 12.95B | |
| -9.59% | 7.84B | |
| +1.82% | 5.5B | |
| +0.02% | 4.61B | |
| +7.94% | 4.61B | |
| -47.74% | 3.4B | |
| +6.42% | 2.66B | |
| -14.59% | 2.08B | |
| +2.74% | 1.79B |
GENTIAN DIAGNOSTICS 
